Directory LogoWelcome to our link directory. Please explore our categories or use the search box if you're looking for anything in particular. If you're a site owner please submit your site or submit articles to the appropriate category.

Categories

Addictions

Alternative Medicine

Children's Health

Dentistry

Disabilities

Diseases & Conditions

Emergency Services

Employment Resources

Eye Care

Fitness & Nutrition

General Health

Hygiene

Institutes

Long Term Care

Medical Centers

Mental Health

Midwifery

Nursing

Organizations

Other

Pet Health

Pharmacy

Public Health & Safety

Senior Health

Skin Care

Traditional Medicine

Weight Loss

Workplace

Last minute


Kansas City Star
Price for push? Botox maker settles charges, pays $600m
Times of India
Allergan, the maker of Botox, agreed to pay $600 million to settle charges that it illegally promoted and sold the drug through 2005 for unapproved uses like treating headaches. That settlement, the latest in a continuing justice department crackdown ...
Maker of Botox pays state in improper marketing settlementBaltimore Sun
Allergan Pleads Guilty, Settles Botox InvestigationABC News
Botox Settlement for $600M Reached to Resolve Lawsuits Over MarketingAboutLawsuits.com
FiercePharma -MedPage Today -The Associated Press
all 660 news articles »

McClatchy Washington Bureau
US employers push increase in cost of healthcare onto workers
Los Angeles Times
A new survey shows an average worker with a family plan pays nearly $4000 a year, up 14% from 2009. Meanwhile, the average employer contribution to a family plan hasn't increased at all. Healthcare educator Rainelle White, background, helps patient ...
Employers Raise Workers' Share of Health CostsWall Street Journal
Workers Pay 14% More for Health Insurance in 2010 to $4000 on AverageBloomberg
Survey: Workers paying more for health insuranceColumbus Dispatch
New York Times -Huffington Post (blog) -Washington Post
all 373 news articles »

Telegraph.co.uk
Common bone drugs linked to esophageal cancer risk
Reuters
LONDON (Reuters) - People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of developing cancer of the gullet or esophagus, a British study found on Friday. ...
Osteoporosis: Is Treatment Worse than the Disease?Food Consumer
Long-Term Use of Bone Drugs May Be Linked to Esophageal CancerBusinessWeek
Bisphosphonates Tied to Esophageal CancerMedPage Today
The Associated Press -BBC News -The Guardian
all 141 news articles »
 

Tag Clouds

care health medicine